Long-term outcomes in leucine-rich glioma inactivated-1 autoimmune encephalitis and associated biomarkers of inflammation and neuronal and glial injury

Long-term outcomes in leucine-rich glioma inactivated-1 autoimmune encephalitis and associated biomarkers of inflammation and neuronal and glial injury

IntroductionLeucine-rich glioma inactivated 1 (LGI1) autoimmune encephalitis (AE) is characterized by seizures, as well as cognitive, memory, and behavioral disturbances. Blood-based biomarkers for inflammation and neuronal and glial injury have been evaluated as potential markers of disease severit...

Full description

Saved in:
Bibliographic Details
Main Authors: Tyler L. Borko, Phillip Winters, Kelli M. Money, Stefan Sillau, Sadie Eggmann, Sean Selva, Alanna Ritchie, Ryan Kammeyer, Gregory P. Owens, Jeffrey L. Bennett, Amanda L. Piquet
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Neurology
Subjects:
autoimmune encephalitis
leucine-rich glioma inactivated 1
biomarkers
neurofilament light chain
glial fibrillary acidic protein
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1583892/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2025.1583892/full

Similar Items